Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06097533
PHASE2

Improvement of Quality of Life by Cannabinoids in Oncologic Patients

Sponsor: University Hospital Schleswig-Holstein

View on ClinicalTrials.gov

Summary

The goal is to explore whether the application of cannabis extract Avextra 10/10 solution is suitable to contribute to an improvement in the symptom burden and well-being of oncological palliative care patients. The primary objective of the study is to demonstrate the improvement in global symptom burden in the intervention arm compared to the placebo control group over a period of 12±2 days, as measured by a percentage change in the value of the Edmonton Symptom Assessment System total symptom distress score (ESAS TSDS) at baseline and after 12±2 days.

Official title: Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BEfindLichkeitsverbesserung Unter CANnabinoid-ExtrakTen Bei Onkologischen Patienten)

Key Details

Gender

All

Age Range

25 Years - Any

Study Type

INTERVENTIONAL

Enrollment

170

Start Date

2024-04-08

Completion Date

2026-11-30

Last Updated

2024-10-26

Healthy Volunteers

No

Interventions

DRUG

Cannabisextrakt Avextra 10/10 Lösung

medical cannabinoids

Locations (4)

Hubertus Wald Tumorzentrum Universitäres Cancer Center Hamburg (UCCH)

Hamburg, Hamburg, Germany

University Hospital Schleswig-Holstein

Kiel, Schleswig-Holstein, Germany

University Hospital Schleswig-Holstein

Kiel, Schleswig-Holstein, Germany

University Hospital Schleswig-Holstein

Lübeck, Schleswig-Holstein, Germany